Duration of sargramostim effects in patients with moderately-to-severely active Crohn's disease (CD): follow-up results from a randomized, double-blind, placebo-controlled trial. - Korzenik,JR.; Dieckgraefe,BK.; Valentine,JF. (Gastroenterology, 2004)